Endocrinology & Diabetes Speciali is categorized under Endocrinologists in Dallas, TX and active since 2012.
Endocrinology & Diabetes Speciali was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Endocrinologists business, which does work in the B2C market, and is classified as a Endocrinologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Maryam Zamanian at the company’s single location by writing to 12222 North Cntl Expressway # 200, Dallas, Texas TX 75243 or by phoning (214) 316-2447. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Endocrinology & Diabetes Speciali |
| Contact Person: | Maryam Zamanian |
| Address: | 12222 North Cntl Expressway # 200, Dallas, Texas 75243 |
| Phone Number: | (214) 316-2447 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Endocrinologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Endocrinology & Diabetes Speciali was started in 2012 to provide professional Endocrinologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Maryam Zamanian for inquiries that concern Endocrinology & Diabetes Speciali by calling the company number (214) 316-2447, as your correspondence is most welcome. Additionally, the physical location of the single location of Endocrinology & Diabetes Speciali can be found at the coordinates 32.91602,-96.76664 as well as the street address 12222 North Cntl Expressway # 200 in Dallas, Texas 75243.
For its online presence, you may visit Endocrinology & Diabetes Speciali’s website at and engage with its social media outlets through on Twitter and on Facebook.